5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole
Structure Info
- Chemspace ID
- CSSB00055493053 (In-Stock Building Blocks)
- MFCD
- MFCD30485958, MFCD30485958
- IUPAC Name
- 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole
- Mol formula
- C13H18BN3O2S
- Mol weight
- 291 Da
- Catalog Number(s)
- BBLS00055493053, BBV-108867625, CSC055493053, EN300-22124333, FCH9015236, bbls00055493053
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.45
- Heavy atoms count
- 20
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.538
- Polar surface area (Å)
- 49
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
![Chemical structure of 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole (C13H18BN3O2S) - CSSB00055493053](/st/structure/200/bcd10f5414def067bf27bc327e5740d7/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DCN%253DCS2%2529N%253DC1.png "C13H18BN3O2S")
- Zoom the structure
- CSSB00055493053
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 985.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 1,031.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 1,078.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,124.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,172.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,295.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,396.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 5,037.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 4-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole - CSSB00120460815](/st/structure/200/332cca2b7ec1751940f9a766b6db2966/CC1%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529SC%253DN1.png)
![Chemical structure of methyl 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole-2-carboxylate - CSSB21229484453](/st/structure/200/c374015b199f51b99218e2282f38ec37/COC%2528%253DO%2529C1%253DNC%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529S1.png)
![Chemical structure of ethyl 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole-2-carboxylate - CSSB21229494733](/st/structure/200/fd9f70bb3801299ce534010f3100aedb/CCOC%2528%253DO%2529C1%253DNC%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529S1.png)
Similarity Analogs
![Chemical structure of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[(thiophen-2-yl)methyl]-1H-pyrazole - CSSB00010198493](/st/structure/200/e569714726681ace93000dad25ec861e/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DCC%253DCS2%2529N%253DC1.png)
![Chemical structure of 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,2-thiazole - CSSB00120463331](/st/structure/200/027a114799d91213d8c1764b0cf0c3b3/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DCC%253DNS2%2529N%253DC1.png)
![Chemical structure of 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,2,3-thiadiazole - CSSB00120462209](/st/structure/200/aac650f612b22443c0efa9bcdcef9c27/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DCN%253DNS2%2529N%253DC1.png)
![Chemical structure of 2-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-oxadiazole - CSSB00120462223](/st/structure/200/9cfcfefb12258ebbec81463a7d34e5f7/CC1%253DNN%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529O1.png)
